Green Rain Energy Holdings (GREH) Fair Value & Analysis
Healthcare · US · Market cap $317K
Fair value as of: Aug 18, 2026
From 2 valuation models · updated today
Share price +8.0% over the past month.
Below-average quality, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- The models converge in a tight band ($0.0079 to $0.0082), unusually little disagreement for a valuation.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 18, 2026.
How to read this chart
60‑month range $0.0025 – $1,000,000 · fair‑value band $0.0079 – $0.0082 · the $0.0081 price screens above the $0.0080 fair value. Dashed = 300-day average. As of Aug 18, 2026.
Analysis
Green Rain Energy Holdings (GREH) currently trades at $0.0081, while our model-based Fair Value estimate is $0.0080, implying the stock looks roughly 1.2% fairly valued today. The Quality Score stands at 29/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: low).
Trailing-twelve-month revenue stands at $2.6K. Net debt stands at $3.2M. Fundamentals as of Aug 18, 2026
Our scenario range runs from $0.0079 (bear case) to $0.0082 (bull case); at $0.0081, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at -1%, GREH screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 2 models by family
Widest divergence: DCF Models ($0.0083) versus Multiples ($0.0080). Highest evidence: EV/EBITDA (54).
Notify me when GREH reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 18, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 30 · Market factors (momentum, volatility) 18
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Green Rain Energy Holdings Inc. engages in development and commercialization of alternative energy technologies, such as wind power and the revitalization of abandoned oil wells. It offers the exoPOWER windTURBINE System, a proprietary, patent-pending wind turbine technology designed to enhance wind power generation efficiency.
Full company description
Green Rain Energy Holdings Inc. engages in development and commercialization of alternative energy technologies, such as wind power and the revitalization of abandoned oil wells. It offers the exoPOWER windTURBINE System, a proprietary, patent-pending wind turbine technology designed to enhance wind power generation efficiency. The company was formerly known as The Now Corporation and changed its name to Green Rain Energy Holdings Inc. in June 2025. Green Rain Energy Holdings Inc. was founded in 1993 and is headquartered in Portland, Oregon.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2010 – FY2025 · reported fiscal years
Green Rain Energy Holdings reported revenue of $21.2K in FY2025 versus $255K in FY2010, a compound −15.3%/yr. Reported net income was −$856K in FY2025.
Watch GREH: get an alert when its fair value changes →
Peer Group
Drug Manufacturers - Specialty & Generic · 625 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Aug 18, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥53.76 | ¥25.94 | -52% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,944 | ₹989.50 | -49% |
| Divi's Laboratories Limited DIVISLAB | ₹8,500 | ₹1,932 | -77% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,915 | ₹1,163 | -76% |
| PharmaEssentia Corporation 6446 | 1,440 TWD | 233.93 TWD | -84% |
| Cipla Limited CIPLA | ₹1,463 | ₹1,001 | -32% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,167 | ₹703.32 | -40% |
| Lupin Limited LUPIN | ₹2,281 | ₹2,477 | +9% |
| Mankind Pharma Limited MANKIND | ₹2,433 | ₹983.11 | -60% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,200 | ₹874.79 | -27% |
Compare Green Rain Energy Holdings with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Green Rain Energy Holdings (GREH) overvalued or undervalued?
What is the fair value of GREH?
What is the quality score of GREH?
What is the revenue of Green Rain Energy Holdings (GREH)?
What is the net profit margin of GREH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Green Rain Energy Holdings and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.